MDA-7/IL-24 inhibits cell survival by inducing apoptosis in nasopharyngeal carcinoma
Cheng Lin1, Haibin Liu2, Li Li2
1Department of Otolaryngology-Head and Neck Surgery, No. 452 Hospital 1 Chengdu 610021, China.
Aims:
Nasopharyngeal carcinoma (NPC) is the most common primary malignancy of the nasopharynx. Due to its local recurrence and distant metastasis, conventional therapy is usually ineffective. MDA-7/IL-24 (melanoma differentiation associated gene 7), a member of the IL10 family of cytokines, inhibits growth of various human cancer cells, but the underlying mechanism is largely unknown. There is no report of mda-7 in nasopharyngeal carcinoma. We aimed to investigate the role of MDA-7/IL-24 in NPC.
Methods:
Immune defective adenoviral vector carrying the gene was produced, infected NPC CNE cells and observed its growth, cell proliferation, apoptosis and the effect of combination with chemotherapy.
Results:
The results showed that (1) MDA-7/IL-24 inhibited NPC CNE cell growth and survival; (2) mda-7 induced cell apoptosis and death; (3) MDA-7/IL-24 in collaboration with chemotherapy induced cell apoptosis significantly; (4) MDA-7/IL-24 induced cell apoptosis by down-regulation of anti-apoptosis molecules such as Bcl-2 and Bcl-xl and up-regulation of caspase 3.
Conclusion:
The results suggested that MDA-7/IL-24 had obvious therapeutic effect in NPC cells. It is verified that adenovirus mediated MDA-7/IL-24 represents a potentially important new approach to NPC therapy.
Insights
Melanoma differentiation associated gene 7 (MDA-7/IL-24) effectively inhibits nasopharyngeal carcinoma (NPC) cell growth and induces apoptosis. Adenovirus-mediated MDA-7/IL-24 shows promise as a novel therapeutic strategy for NPC.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Nasopharyngeal carcinoma (NPC) presents challenges due to recurrence and metastasis, often rendering conventional therapies ineffective.
- The therapeutic potential of melanoma differentiation associated gene 7 (MDA-7/IL-24), a cytokine inhibiting various cancer cells, in NPC remains largely unexplored.
Purpose of the Study:
- To investigate the role and therapeutic efficacy of MDA-7/IL-24 in nasopharyngeal carcinoma (NPC) cells.
- To determine if MDA-7/IL-24 can inhibit NPC cell growth and induce apoptosis.
Main Methods:
- Production of an immune-defective adenoviral vector carrying the MDA-7/IL-24 gene.
- Infection of NPC CNE cells with the vector to assess effects on cell growth, proliferation, and apoptosis.
- Evaluation of MDA-7/IL-24 in combination with chemotherapy.
Main Results:
- MDA-7/IL-24 significantly inhibited NPC CNE cell growth and survival.
- MDA-7/IL-24 induced cancer cell apoptosis and death.
- Combined treatment with MDA-7/IL-24 and chemotherapy enhanced apoptosis induction.
- Apoptosis was mediated by down-regulation of Bcl-2 and Bcl-xl, and up-regulation of caspase 3.
Conclusions:
- Adenovirus-mediated delivery of MDA-7/IL-24 demonstrates significant therapeutic effects against NPC cells.
- MDA-7/IL-24 represents a promising novel therapeutic approach for nasopharyngeal carcinoma.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
02:23Abnormal Proliferation
01:22MicroRNAs